Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quality Technology International (QTI) is a life sciences company specializing in natural animal health and nutrition solutions. The company focuses on the development and commercialization of direct-fed microbials (DFMs), probiotics, and prebiotic products designed to improve gut health and performance in livestock, including poultry, swine, and cattle. QTI's research-driven approach aims to provide alternatives to traditional antibiotics by leveraging beneficial bacteria to manage pathogens like Salmonella and E. coli. Their product portfolio includes brands such as Q-Biotic and Calsporin, which are widely used in the agricultural industry to enhance animal well-being and productivity. Headquartered in Elgin, Illinois, QTI serves the global agricultural market with evidence-based nutritional interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QTI Corporation.